<DOC>
	<DOC>NCT00751452</DOC>
	<brief_summary>determine the interest of the dosage of citrullinemia to monitor the bowel damage after allogeneic bone marrow transplantation in children.</brief_summary>
	<brief_title>Citrulline Allo. Evaluation of Citrullinemia as a Marker of Bowel Damage After Allogeneic Bone Marrow Transplantation in Children</brief_title>
	<detailed_description>30 children included. Dosage of citrullinemia on day -7, day 0 and every week up to 100 days after BMT. Histological examination and extensive infectious screening in case of persistent digestive symptoms (more than 3 days). Two groups of patients regarding on digestive involvement. Comparison of the values of citrullinemia between these two groups.</detailed_description>
	<mesh_term>Citrullinemia</mesh_term>
	<criteria>0 to 18 years allogeneic bone marrow transplantation for malignant or benign disease affiliation to French sécurité sociale parent's consent severe gastrointestinal involvement before transplant previous digestive surgery</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>January 2011</verification_date>
	<keyword>Children</keyword>
	<keyword>Allogeneic bone marrow transplantation</keyword>
	<keyword>Intestinal damage</keyword>
	<keyword>Citrulline</keyword>
	<keyword>Graft versus Host Disease</keyword>
	<keyword>0 to 18 years old</keyword>
</DOC>